Life Sciences Research for Lifelong Health

Amanda Collier

Amanda graduated with a First in Molecular Cell Biology from the University of York in 2014. During her degree, she undertook a research placement at the Regenerative Medicine Unit at Pfizer Neusentis, where she studied the role of Sox2 in neural stem cells and reprogramming. Funded by an MRC Studentship (www.mrc.ac.uk/Fundingopportunities/Studentships), Amanda joined the Babraham Institute in 2014 to investigate the function and regulation of Polycomb-Group proteins in stem cell fate decisions.

Latest Publications

Assessing the Safety of Human Pluripotent Stem Cells and Their Derivatives for Clinical Applications.

Andrews PW, Ben-David U, Benvenisty N

Stem cell reports
9 2213-6711:1-4 (2017)

PMID: 28700896

Global reorganisation of cis-regulatory units upon lineage commitment of human embryonic stem cells.

Freire-Pritchett P, Schoenfelder S, Várnai C

eLife
6 2050-084X: (2017)

PMID: 28332981

Derivation and Culture of Epiblast Stem Cell (EpiSC) Lines.

Rugg-Gunn P

Cold Spring Harbor protocols
2017 1559-6095:pdb.prot093971 (2017)

PMID: 28049783

Derivation and Culture of Extra-Embryonic Endoderm Stem Cell Lines.

Rugg-Gunn P

Cold Spring Harbor protocols
2017 1559-6095:pdb.prot093963 (2017)

PMID: 28049782